Breast Cancer
Conditions
Keywords
Breast cancer, Exercise, Biomarkers
Brief summary
It is important to confirm health benefits experienced by breast cancer survivors after participation in a physical activity behavior change intervention. One such potential benefit is a reduction in harmful inflammation that might lead to increased symptoms or cancer risk. Because little is known about how physical activity behavior change interventions influence inflammation in breast cancer survivors, the investigators study will measure inflammation with blood markers known as cytokines among breast cancer survivors before and after a physical activity intervention. Such information has the potential to lead to improved physical functioning, reduction in bothersome symptoms (e.g., fatigue), and reduced cancer risk in breast cancer survivors.
Interventions
BEHAVIORALExercise Behavior Change
Multidisciplinary
Sponsors
University of Alabama at Birmingham
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Female breast cancer patients between the ages of 18 and 70 years of age with a diagnosis of Stage I, II, or IIIA breast cancer who are not currently receiving (and do not plan to receive during the study duration) chemotherapy or radiation therapy. The participant may be taking longer term therapies such as aromatase inhibitors, estrogen receptor modulators, etc. * If the patient has undergone a surgical procedure, must be at least 8 weeks post-procedure. * English speaking. * Medical clearance for participation provided by primary care physician or oncologist.
Exclusion criteria
* Diagnosis of dementia or organic brain syndrome. * Medical, psychological, or social characteristic that would interfere with ability to fully participate in program activities and assessments (e.g., psychosis, schizophrenia, etc.). * Contraindication to participation in a regular physical activity program. * Metastatic or recurrent disease * Inability to ambulate * Engaged in ≥ 60 minutes of vigorous physical activity or ≥ 150 minutes of moderate plus vigorous activity per week during the past month. * Anticipates undergoing elective surgery during the duration of the intervention which would interfere with intervention participation (e.g., breast reconstructive surgery). * Participant does not live or work within 50 miles of the study site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in pro-inflammatory and anti-inflammatory cytokines | baseline and 3 months |
Secondary
| Measure | Time frame |
|---|---|
| Change in fatigue, sleep and muscle strength | baseline and 3 months |
Countries
United States
Outcome results
None listed